ENDOBIOS biotech has a dual specialty expertise: the disruptive discovery and development of new bioactive natural products from microorganisms (bacteria, fungi), and the first-time biotechnological application related to endobacterial symbionts in the eukaryotic cytoplasm. Besides custom services, ENDOBIOS also provides consulting in new natural products discovery and development (for Pharma, Agro or Cosmetic application), and in endosymbiotic bacteria living in eukaryotic hosts.Our currently most advanced project is the mid-preclinical trial development of a drug candidate (isolated from a marine fungus) which is active against central nervous system disorders.ENDOBIOS has proprietary methods for the induction of novel neuropathic agents, and also of antibiotics from microbial sources.